HomeCompareGPAGF vs MRK

GPAGF vs MRK: Dividend Comparison 2026

GPAGF yields 1.56% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.8K in total portfolio value
10 years
GPAGF
GPAGF
● Live price
1.56%
Share price
$18.55
Annual div
$0.29
5Y div CAGR
15.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.0K
Annual income
$813.00
Full GPAGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GPAGF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGPAGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GPAGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GPAGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GPAGF
Annual income on $10K today (after 15% tax)
$132.88/yr
After 10yr DRIP, annual income (after tax)
$691.05/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,637.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GPAGF + MRK for your $10,000?

GPAGF: 50%MRK: 50%
100% MRK50/50100% GPAGF
Portfolio after 10yr
$40.9K
Annual income
$5,305.57/yr
Blended yield
12.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GPAGF
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
2.9
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GPAGF buys
0
MRK buys
0
No recent congressional trades found for GPAGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGPAGFMRK
Forward yield1.56%2.76%
Annual dividend / share$0.29$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR15.5%32.7%
Portfolio after 10y$25.0K$56.8K
Annual income after 10y$813.00$9,798.13
Total dividends collected$4.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: GPAGF vs MRK ($10,000, DRIP)

YearGPAGF PortfolioGPAGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,881$180.57$11,206$366.19$325.00MRK
2$11,854$212.07$12,650$502.35$796.00MRK
3$12,933$249.41$14,407$694.19$1.5KMRK
4$14,133$293.73$16,585$967.82$2.5KMRK
5$15,468$346.46$19,342$1,363.89$3.9KMRK
6$16,960$409.33$22,913$1,947.19$6.0KMRK
7$18,632$484.46$27,662$2,823.89$9.0KMRK
8$20,511$574.49$34,159$4,173.35$13.6KMRK
9$22,629$682.66$43,337$6,308.80$20.7KMRK
10$25,026$813.00$56,776$9,798.13$31.8KMRK

GPAGF vs MRK: Complete Analysis 2026

GPAGFStock

Gruma, S.A.B. de C.V., together with its subsidiaries, produces and sells corn flour, tortillas, and other related products. The company offers corn flour, grits snacks and/or cereal, beer grits, and polenta; prepared corn or wheat flours for pancakes, cakes, crêpes, brownies, churros, pizza dough, cachapas, sweet arepitas, etc.; corn and wheat tortillas; tortilla chips, taco shells, and tostadas; flatbreads, including wraps, pita bread, naan, chapatti, pizza doughs, piadina, breakfast breads, and crackers; sauces/dips; palmito; pasta; marinades; and rice and oats. It markets and sells its products under the Maseca, Mission, Guerrero, Tosty, TortiRicas, Rumba, La Cima, Masa Rica, Del Fogón, Delicados, Arroz Luisiana, Tortimasa, Juana, Minsa, Mimasa, Bravos, Tronaditas, and Mexifoods brand names. The company also designs, manufactures, and commercializes machines for production of corn and wheat flour tortillas, and tortilla chips under the TORTEC and RODOTEC names; and designs and manufactures equipment for corn masa flour, such as corn milling machinery, as well as provides engineering, design, and construction services. It provides its products to retail customers, including supermarkets, mass merchandisers, membership stores, and independent stores; food service customers comprising chain restaurants, food service distributors, schools, hospitals, and military; and tortilla manufacturers and corn chip producers. The company distributes its products primarily through independent distributors and wholesalers. It has operations in Mexico, the United States, Central America, Europe, Asia, and Oceania. Gruma, S.A.B. de C.V. was founded in 1949 and is headquartered in San Pedro Garza García, Mexico.

Full GPAGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GPAGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GPAGF vs SCHDGPAGF vs JEPIGPAGF vs OGPAGF vs KOGPAGF vs MAINGPAGF vs JNJGPAGF vs ABBVGPAGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.